Dear Trader...
Fund
Houses Recommendations
- Macquarie on Lenskart: Initiate
Outperform on Company, target price at Rs 530/Sh (Positive)
- Investec on USL: Maintain Buy on
Company, target price at Rs 1673/Sh (Positive)
- GS on Max Health: Maintain Buy on
Company, target price at Rs 1325/Sh (Positive)
- Kotak on SBI Cards: Maintain Overweight
on Company, target price at Rs 975/Sh (Positive)
- Citi on Voltas: Maintain Buy on
Company, target price at Rs 1775/Sh (Positive)
- Jefferies on Voltas: Maintain Buy on
Company, target price at Rs 1635/Sh (Positive)
- CLSA on Dalmia Bharat: Maintain
Outperform on Company, target price at Rs 2650/Sh
(Positive)
- Citi on Divis Lab: Maintain Buy on
Company, target price at Rs 9140/Sh (Positive)
- Jefferies on Indian IT stocks: Steady
Growth Guidance Set to Weigh on Indian IT (Neutral)
- Jefferies on India Strategy: Another
potential explanation for the renewed rupee weakness is that the RBI has turned
unambiguously dovish (Neutral)
- MS on HCL Tech: Maintain Equal
weight on Company, target price at Rs 1680/Sh
(Neutral)
- Nuvama on Voltas: Maintain Neutral on
Company, target price at Rs 1170/Sh (Neutral)
- Nuvama on SAIL: Downgrade to Reduce
on Company, cut target price at Rs 106/Sh (Negative)
Warm Regards...
Join Channel :- https://whatsapp.com/channel/0029Va6EjWxA2pL2q3fKm035
The securities quoted are
for illustration only and are not recommendatory. Investment in securities
market are subject to market risks. Read and agree Disclaimer and related all
the documents carefully before investing, mentioned on www.nikhilbhatt.in
No comments:
Post a Comment